Follow
Verena Kufner
Verena Kufner
Institute of Medical Virology, University of Zurich
Verified email at virology.uzh.ch
Title
Cited by
Cited by
Year
Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples
DW Lewandowska, O Zagordi, FD Geissberger, V Kufner, S Schmutz, ...
Microbiome 5, 1-13, 2017
572017
SARS-CoV-2 variants reveal features critical for replication in primary human cells
MO Pohl, I Busnadiego, V Kufner, I Glas, U Karakus, S Schmutz, M Zaheri, ...
PLoS biology 19 (3), e3001006, 2021
562021
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
FX López-Labrador, JR Brown, N Fischer, H Harvala, S Van Boheemen, ...
Journal of Clinical Virology 134, 104691, 2021
562021
Two years of viral metagenomics in a tertiary diagnostics unit: evaluation of the first 105 cases
V Kufner, A Plate, S Schmutz, DL Braun, HF Günthard, R Capaul, ...
Genes 10 (9), 661, 2019
452019
Viral metagenomics in the clinical realm: lessons learned from a Swiss-wide ring trial
T Junier, M Huber, S Schmutz, V Kufner, O Zagordi, S Neuenschwander, ...
Genes 10 (9), 655, 2019
412019
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples
JJC de Vries, JR Brown, N Fischer, IA Sidorov, S Morfopoulou, J Huang, ...
Journal of Clinical Virology 141, 104908, 2021
342021
Meningitis and epididymitis caused by Toscana virus infection imported to Switzerland diagnosed by metagenomic sequencing: a case report
F Tschumi, S Schmutz, V Kufner, M Heider, F Pigny, B Schreiner, ...
BMC infectious diseases 19, 1-4, 2019
272019
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
M Marconato, IA Abela, A Hauser, M Schwarzmüller, R Katzensteiner, ...
The Journal of Clinical Investigation 132 (12), 2022
262022
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data
SA Nadeau, TG Vaughan, C Beckmann, I Topolsky, C Chen, E Hodcroft, ...
Science translational medicine 15 (680), eabn7979, 2022
222022
Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office
D Weissberg, J Böni, SK Rampini, V Kufner, M Zaheri, PW Schreiber, ...
Antimicrobial Resistance & Infection Control 9, 1-8, 2020
222020
Metagenomic virome sequencing in living donor and recipient kidney transplant pairs revealed JC polyomavirus transmission
PW Schreiber, V Kufner, K Hübel, S Schmutz, O Zagordi, A Kaur, ...
Clinical Infectious Diseases 69 (6), 987-994, 2019
192019
External quality assessment of SARS-CoV-2 sequencing: an ESGMD-SSM pilot trial across 15 European laboratories
F Wegner, T Roloff, M Huber, S Cordey, A Ramette, Y Gerth, C Bertelli, ...
Journal of clinical microbiology 60 (1), e01698-21, 2022
152022
Quantifying SARS-CoV-2 spread in Switzerland based on genomic sequencing data
S Nadeau, C Beckmann, I Topolsky, T Vaughan, E Hodcroft, T Schär, ...
medRxiv, 2020.10. 14.20212621, 2020
122020
Nosocomial COVID-19 incidence and secondary attack rates among patients of tertiary care center, Zurich, Switzerland
A Wolfensberger, V Kufner, M Zaheri, M Zeeb, I Nortes, PW Schreiber, ...
Emerging Infectious Diseases 28 (10), 2087, 2022
62022
Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples. Microbiome. 2017; 5 (1): 94
DW Lewandowska, O Zagordi, FD Geissberger, V Kufner, S Schmutz, ...
PubMed Abstract| Publisher Full Text| Free Full Text, 0
6
Distinct phenotypes of SARS-CoV-2 isolates reveal viral traits critical for replication in primary human respiratory cells
MO Pohl, I Busnadiego, V Kufner, I Glas, U Karakus, S Schmutz, M Zaheri, ...
52020
Viral metagenomics in the clinical realm: lessons learned from a Swiss-wide ring trial. Genes (Basel) 10: 655
T Junier, M Huber, S Schmutz, V Kufner, O Zagordi, S Neuenschwander, ...
52019
Rapid and sensitive single-sample viral metagenomics using Nanopore Flongle sequencing
I Pichler, S Schmutz, G Ziltener, M Zaheri, V Kufner, A Trkola, M Huber
Journal of Virological Methods 320, 114784, 2023
32023
Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy
M Marconato, IA Abela, A Hauser, M Schwarzmüller, R Katzensteiner, ...
medRxiv, 2021.12. 09.21267513, 2021
22021
SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway (preprint)
H Xu, SA Chitre, IA Akinyemi, JC Loeb, JA Lednicky, MT McIntosh, ...
12020
The system can't perform the operation now. Try again later.
Articles 1–20